Children with SCD who have sleep issues, such as sustained low blood oxygen during sleep, require more healthcare resources, ...

Pociredir 12 mg dose has shown favorable safety and signs of efficacy in a Phase 1b trial of sickle cell disease (SCD).

The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of ...

The Centers for Medicare & Medicaid Services (CMS) has announced that 33 states, along with the District of Columbia and ...

Because sickle cell disease is a multisystemic disorder, it can result in a wide range of symptoms, explains columnist.

A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...

The first patient with SCD has been dosed in a clinical trial of HBI-002, an experimental, low-dose liquid formulation of carbon monoxide.

A $3.2M grant will be sued to continue investigating machine learning to identify sickle cell disease patients at risk of kidney disease.

The gene-editing therapy OTQ923 normalized brain blood flow in 3 sickle cell disease patients, suggesting it may lower stroke risk, a study says.

Acute chest syndrome associated with sickle cell is driven by the abnormal activation of the complement cascade, per a study.

The last healthy volunteer has completed the study protocol in a clinical trial testing the oral carbon monoxide treatment HBI-002 for SCD.